SpliSense
RNA-based Treatment for Genetic Diseases
Active
B
Startup
Jerusalem
Founded 2016-11
SpliSense is a clinical stage company developing transformative RNA-based treatments for unmet needs relating to diverse pulmonary diseases. Its treatment is based on clinically validated Antisense Oligonucleotide (ASO) technology, delivered non-invasively by inhalation to the lungs. The company is focused on a variety of innovative therapies, in different…
SectorHealth Tech & Life Sciences
StageB
Total raised$41.5M
Employees17
Founded2016-11
HQJerusalem
Crunchbasesplisense
Patents1
Confidence89
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology